Ballast Advisors LLC Buys 294 Shares of Danaher Corporation $DHR

Ballast Advisors LLC boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 6.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,946 shares of the conglomerate’s stock after purchasing an additional 294 shares during the period. Ballast Advisors LLC’s holdings in Danaher were worth $977,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Brighton Jones LLC lifted its position in Danaher by 47.3% during the second quarter. Brighton Jones LLC now owns 10,390 shares of the conglomerate’s stock valued at $2,052,000 after purchasing an additional 3,335 shares during the period. Stegent Equity Advisors Inc. raised its position in Danaher by 60.5% in the second quarter. Stegent Equity Advisors Inc. now owns 1,764 shares of the conglomerate’s stock worth $348,000 after acquiring an additional 665 shares during the period. Linden Thomas Advisory Services LLC bought a new position in Danaher in the second quarter worth approximately $252,000. RedJay Asset Management Inc. raised its position in Danaher by 50.0% in the second quarter. RedJay Asset Management Inc. now owns 15,000 shares of the conglomerate’s stock worth $2,963,000 after acquiring an additional 5,000 shares during the period. Finally, Kornitzer Capital Management Inc. KS raised its position in Danaher by 1.0% in the second quarter. Kornitzer Capital Management Inc. KS now owns 9,746 shares of the conglomerate’s stock worth $1,925,000 after acquiring an additional 95 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Trading Up 0.1%

Shares of NYSE DHR opened at $223.03 on Friday. The stock has a market capitalization of $157.54 billion, a P/E ratio of 45.99, a PEG ratio of 3.41 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The business’s 50 day moving average is $202.73 and its two-hundred day moving average is $198.53. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the business earned $1.71 EPS. The company’s quarterly revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 26.39%.

Analysts Set New Price Targets

Several research analysts have weighed in on DHR shares. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday. Deutsche Bank Aktiengesellschaft increased their price target on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday. Barclays increased their price target on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday. UBS Group decreased their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Finally, Bank of America cut their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.